According to CymaBay Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 105,717,996. At the end of 2023 the company had 105,717,996 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.10 B | 20.4% |
2022 | 87.8 M | 27.21% |
2021 | 69.02 M | 0.2% |
2020 | 68.88 M | 0.2% |
2019 | 68.74 M | 16.28% |
2018 | 59.12 M | 47.67% |
2017 | 40.03 M | 70.75% |
2016 | 23.44 M | 8.18% |
2015 | 21.67 M | 60.93% |
2014 | 13.46 M | -4.24% |
2013 | 14.06 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 5,241.57% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 2,023,000,000 | 1,813.58% | ๐บ๐ธ USA |
Xencor XNCR | 60,621,534 | -42.66% | ๐บ๐ธ USA |
PTC Therapeutics
PTCT | 75,377,997 | -28.70% | ๐บ๐ธ USA |